ROVAFOVIR ETALAFENAMIDE CITRATE
UNII PQY41X26YL

Substance Identification & Data

This profile provides standardized clinical and technical data for Rovafovir Etalafenamide Citrate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) PQY41X26YL.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1034559-30-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

PQY41X26YL

CAS Registry Number

1034559-30-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ROVAFOVIR ETALAFENAMIDE CITRATE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C21H24FN6O6P.C6H8O7

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

UQNIBOGIUNYYCZ-XBRDKGPFSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C171853

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

44603335

Unique identification number in the NCBI database of chemical substances.

USAN ID

HI-12

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

FC1=C[C@@H](OC[P@](=O)(N[C@@H](C)C(=O)OCC)Oc2ccccc2)O[C@H]1n3cnc4c(ncnc43)N.OC(C(O)=O)(CC(O)=O)CC(O)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Rovafovir Etalafenamide Citrate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ROVAFOVIR ETALAFENAMIDE CITRATE

Common Names & Synonyms

ROVAFOVIR ETALAFENAMIDE CITRATE [USAN]

Systematic Nomenclature

ETHYL (2S)-(((S)-((((2R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-4-FLUORO-2,5-DIHYDROFURAN-2-YL)OXY)METHYL)PHENOXYPHOSPHONOYL)AMINO)PROPANOATE, 2-HYDROXYPROPANE-1,2,3-TRICARBOXYLATE (1:1)

SYS

L-ALANINE, N-((S)-((((2R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-4-FLUORO-2,5-DIHYDRO-2-FURANYL)OXY)METHYL)PHENOXYPHOSPHINYL)-, ETHYL ESTER, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1)

SYS